There are two medications you can take for heartburn and acid reflux: Proton pump inhibitors (PPIs), medications that significantly reduce stomach acid production for long-term use (although they should be weaned slowly off) H2 blockers, drugs that reduce stomach acid production by blocking histamine signals in the stomach lining, are better for occasional use While PPIs are generally more effective at providing 24-hour acid suppression and healing esophageal damage, they can increase the risk of nutrient deficiencies with long-term use
This hypothesis was confirmed when we found that incubation of H
25 mg/day oral Tirzepatide 15 mg/week Retatrutide 12 mg/week Liraglutide 3.0 mg/day Factor Peak trial weight loss Semaglutide -14.9% at 68 wks (STEP 1) Tirzepatide -22.5% at 72 wks (SURMOUNT-1) Retatrutide -28.7% at 68 wks (TRIUMPH-4) Liraglutide -8% at 56 wks (SCALE) Factor FDA status (June 2026) Semaglutide Approved (T2D, obesity, CVD, MASH, CKD, oral) Tirzepatide Approved (T2D, obesity) Retatrutide Investigational - Phase 3 Liraglutide Approved (Saxenda obesity, Victoza T2D) Factor CV outcomes data Semaglutide Yes - SELECT (20% MACE drop) Tirzepatide SURPASS-CVOT ongoing Retatrutide TRIUMPH-3 ongoing Liraglutide Yes - LEADER (13% MACE drop) These compounds are not interchangeable
But GLP-1 skin depletion also involves real losses in collagen and structural support that require a longer-term approach
Let me know if youd like a carousel caption or hashtag set too
